Literature DB >> 26688675

Systemic Treatment in Premenopausal Patients with Breast Cancer.

Georg Pfeiler1.   

Abstract

Entities:  

Year:  2015        PMID： 26688675      PMCID： PMC4677713          DOI： 10.1159/000441614

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN： 1661-3791            Impact factor:   2.860


× No keyword cloud information.
  6 in total

1.  Prognostic impact of pregnancy after breast cancer according to estrogen receptor status: a multicenter retrospective study.

Authors:  Hatem A Azim; Niels Kroman; Marianne Paesmans; Shari Gelber; Nicole Rotmensz; Lieveke Ameye; Leticia De Mattos-Arruda; Barbara Pistilli; Alvaro Pinto; Maj-Britt Jensen; Octavi Cordoba; Evandro de Azambuja; Aron Goldhirsch; Martine J Piccart; Fedro A Peccatori
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

2.  Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.

Authors:  Halle C F Moore; Joseph M Unger; Kelly-Anne Phillips; Frances Boyle; Erika Hitre; David Porter; Prudence A Francis; Lori J Goldstein; Henry L Gomez; Carlos S Vallejos; Ann H Partridge; Shaker R Dakhil; Agustin A Garcia; Julie Gralow; Janine M Lombard; John F Forbes; Silvana Martino; William E Barlow; Carol J Fabian; Lori Minasian; Frank L Meyskens; Richard D Gelber; Gabriel N Hortobagyi; Kathy S Albain
Journal:  N Engl J Med       Date:  2015-03-05       Impact factor: 91.245

Review 3.  Reduced progesterone levels explain the reduced risk of breast cancer in obese premenopausal women: a new hypothesis.

Authors:  Mitch Dowsett; Elizabeth Folkerd
Journal:  Breast Cancer Res Treat       Date:  2014-11-21       Impact factor: 4.872

4.  Endocrine therapy plus zoledronic acid in premenopausal breast cancer.

Authors:  Michael Gnant; Brigitte Mlineritsch; Walter Schippinger; Gero Luschin-Ebengreuth; Sabine Pöstlberger; Christian Menzel; Raimund Jakesz; Michael Seifert; Michael Hubalek; Vesna Bjelic-Radisic; Hellmut Samonigg; Christoph Tausch; Holger Eidtmann; Günther Steger; Werner Kwasny; Peter Dubsky; Michael Fridrik; Florian Fitzal; Michael Stierer; Ernst Rücklinger; Richard Greil; C Marth
Journal:  N Engl J Med       Date:  2009-02-12       Impact factor: 91.245

5.  Menstrual cycle and surgical treatment of breast cancer: findings from the NCCTG N9431 study.

Authors:  Clive S Grant; James N Ingle; Vera J Suman; Daniel A Dumesic; D Lawrence Wickerham; Richard D Gelber; Patrick J Flynn; Lorna M Weir; Mattia Intra; Wayne O Jones; Edith A Perez; Lynn C Hartmann
Journal:  J Clin Oncol       Date:  2009-06-01       Impact factor: 44.544

6.  Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer.

Authors:  G Pfeiler; R Königsberg; P Hadji; F Fitzal; M Maroske; G Dressel-Ban; J Zellinger; R Exner; M Seifert; C Singer; M Gnant; P Dubsky
Journal:  Br J Cancer       Date:  2013-09-03       Impact factor: 7.640
  6 in total
  2 in total

1.  Evaluation of Reproductive Concerns and Biographical Impact of Breast Cancer in Young Patients.

Authors:  Maximiliane Burgmann; Kerstin Hermelink; Alex Farr; Friederike van Meegen; Annika Heiduschk; Jutta Engel; Thomas Kolben; Tom Degenhardt; Nina Ditsch; Sven Mahner; Nadia Harbeck; Rachel Würstlein
Journal:  Breast Care (Basel)       Date:  2018-02-01       Impact factor: 2.860

2.  Obesity, Dietary Factors, Nutrition, and Breast Cancer Risk.

Authors:  Annina Seiler; Michelle A Chen; Ryan L Brown; Christopher P Fagundes
Journal:  Curr Breast Cancer Rep       Date:  2018-01-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.